The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway

Cited by (598)

Items 401–500 of 598

1. N-truncated Aβ peptides in complex fluids unraveled by new specific immunoassays
   Sébastien Ranaldi, Céline Caillava, Sylvie Promé, Laëtitia Rubrecht, Sandra Cobo, Nicolas Salvetat, Emilie Du Paty, Pascale Galéa, Gudrun Aldrian, Dung Le‐Nguyen et al. · 2012 · Neurobiology of Aging
2. Secretases as targets for beta‐amyloid lowering drugs
   Jochen Walter, Christian Haass · 2002 · Drug Development Research
3. Statistics Commentary Series
   David L. Streiner · 2018 · Journal of Clinical Psychopharmacology
4. Positive–negative epitope-tagging of β amyloid precursor protein to identify inhibitors of Aβ processing
   Dietmar Seiffert, Thomas J. Mitchell, Andrew M. Stern, Arthur Roach, Yutian Zhan, Reinhard Grzanna · 2000 · Molecular Brain Research
5. What do we learn from a few familial Alzheimer’s disease cases?
   Christian Haass, Ralf Baumeister · 1998 · Journal of neural transmission. Supplementum
6. Presenilin-1 mutations associated with familial Alzheimer’s disease do not disrupt protein transport from the endoplasmic reticulum to the Golgi apparatus
   Yizheng Tan, Jin Hong, Tam Doan, Lisa McConlogue, William A. Maltese · 1998 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
7. Mucin-Type O-Glycosylation Proximal to β-Secretase Cleavage Site Affects APP Processing and Aggregation Fate
   YashoNandini Singh, Deepika Regmi, David Ormaza, Ramya Ayyalasomayajula, Nancy Vela, Gustavo Mundim, De-Guo Du, D. Minond, M. Cudic · 2022 · Frontiers in Chemistry
8. PS1 Affects the Pathology of Alzheimer’s Disease by Regulating BACE1 Distribution in the ER and BACE1 Maturation in the Golgi Apparatus
   Nuomin Li, Yunjie Qiu, Hao Wang, Juan Zhao, Hong Qing · 2022 · International Journal of Molecular Sciences
9. The Icelandic Mutation (APP-A673T) Is Protective against Amyloid Pathology In Vivo
   Sho Shimohama, Ryo Fujioka, Naomi Mihira, Misaki Sekiguchi, Luca Sartori, Daisuke Joho, Takashi Saito, Takaomi C. Saido, Jin Nakahara, Tomohito Hino et al. · 2024 · Journal of Neuroscience
10. Modeling of age‐dependent amyloid accumulation and γ‐secretase inhibition of soluble and insoluble Aβ in a transgenic mouse model of amyloid deposition
    JOANNA R. PARKINSON, Bart A. Ploeger, Paulina Appelkvist, Anna Bogstedt, Karin Dillner Bergstedt, Susanna Eketjäll, Sandra A. G. Visser · 2013 · Pharmacology Research & Perspectives
11. GSNgene frameshift mutations in Alzheimer’s disease
    Yaling Jiang, Meidan Wan, Xuewen Xiao, Zhuojie Lin, Xixi Liu, Yafang Zhou, Xinxin Liao, Jingyi Lin, Hui Zhou, Lu Zhou et al. · 2023 · Journal of Neurology Neurosurgery & Psychiatry
12. Deletion of SERF2 in mice delays embryonic development and alters amyloid deposit structure in the brain
    Esther Stroo, Leen Janssen, Olga Sin, Wytse Hogewerf, Mirjam H. Koster, Liesbeth Harkema, Sameh A. Youssef, Natalie Beschörner, Anouk H. G. Wolters, Björn Bakker et al. · 2023 · Life Science Alliance
13. Could Lipoprotein Lipase Play a Role in Alzheimer's Disease?
    Jean‐François Blain, Judes Poirier · 2004 · The Scientific World JOURNAL
14. Engrampigenetics: Epigenetics of engram memory cells
    Cristian Ripoli · 2016 · Behavioural Brain Research
15. News from Mars: Two-Tier Paradox, Intracellular PCR, Chimeric Junction Shift, Dark Matter mRNA and Other Remarkable Features of Mammalian RNA-Dependent mRNA Amplification. Implications for Alzheimer’s Disease, RNA-Based Vaccines and mRNA Therapeutics
    Vladimir Volloch, Sophia Rits‐Volloch · 2019 · Annals of Integrative Molecular Medicine
16. Impact of Silibinin A on Bioenergetics in PC12APPsw Cells and Mitochondrial Membrane Properties in Murine Brain Mitochondria
    Carsten Esselun, Bastian Bruns, Stephanie Hagl, Rekha Grewal, Gunter Peter Eckert · 2021 · Antioxidants
17. Genetic markers in the diagnosis of Alzheimer's disease
    Ekaterina A. Rogaeva, Anurag Tandon, Peter St George‐Hyslop · 2001 · Journal of Alzheimer s Disease
18. Enhanced aggregation of β-amyloid-containing peptides by extracellular matrix and their degradation by the 68 kDa serine protease prepared from human brain
    Akira Matsumoto, Taira Enomoto, Yoshisada Fujiwara, Hisamitsu Baba, Reiko Matsumoto · 1996 · Neuroscience Letters
19. A multi-looping chromatin signature predicts dysregulated gene expression in neurons with familial Alzheimer’s disease mutations
    Harshini Chandrashekar, Zoltán Simándi, Heesun Choi, Han-Seul Ryu, Abraham J. Waldman, Alexandria Nikish, Srikar S Muppidi, Wanfeng Gong, Dominik Paquet, Jennifer E. Phillips‐Cremins · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
20. Mutations in the Amyloid-β Protein Precursor Reduce Mitochondrial Function and Alter Gene Expression Independent of 42-Residue Amyloid-β Peptide
    Chad A. Pope, Heather Wilkins, Russell Howard Swerdlow, Michael S. Wolfe · 2021 · Journal of Alzheimer s Disease
21. What Makes a Prion
    Kyle S. MacLea · 2016 · International review of cytology
22. The Alzheimer s plaques tangles and memory deficits may have a common origin - part II Therapeutic rationale
    Ming Chen · 1998 · Frontiers in bioscience
23. Discovery of an ApoE4-targeted small-molecule SirT1 enhancer for the treatment of Alzheimer’s disease
    Jesus J. Campagna, Sujyoti Chandra, Bruce Teter, Whitaker Cohn, Johnny D. Pham, Young-Sug Kim, Barbara M. Jagodzinska, Kanagasabai Vadivel, Parvez Alam, Tina V. Bilousova et al. · 2025 · Scientific Reports
24. A Structure-Based Discovery Platform for BACE2 and the Development of Selective BACE Inhibitors
    Yu‐Chen Yen, Annalissa M. Kammeyer, Jagannadharao Tirlangi, Arun Kumar Ghosh, Andrew D. Mesecar · 2021 · ACS Chemical Neuroscience
25. Advancement in Analytical Techniques for Determining the Activity of β-Site Amyloid Precursor Protein Cleaving Enzyme 1
    Jie Fan, Xiuhua Wei, Hui Yuan Dong, Yintang Zhang, Yanli Zhou, Maotian Xu, Guoqing Xiao · 2022 · Critical Reviews in Analytical Chemistry
26. Development of a Novel β-Secretase Binding Assay Using the AlphaScreen Platform
    Zhao Ren, Danny Tam, Ying‐zi Xu, David W.G. Wone, Shendong Yuan, Hing Leung Sham, Harry Cheung, Karin J. Regnström, Xiaohua Chen, Donald Rudolph et al. · 2013 · SLAS DISCOVERY
27. Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization
    Triana Amen, Daniel Kaganovich · 2016 · Microbial Cell
28. Interaction Models of Substrate Peptides and β-Secretase Studied by NMR Spectroscopy and Molecular Dynamics Simulation
    Jee-Young Lee, Sung-Ah Lee, Jin‐Kyoung Kim, Chi‐Bom Chae, Yangmee Kim · 2009 · Molecules and Cells
29. Baculovirus‐infected cells do not produce the amyloid peptide of Alzheimer's disease from its precursor
    Rachid Essalmani, J.M. Guillaume, Luc Mercken, Jean Noël Octave · 1996 · FEBS Letters
30. Voluntary wheel running decreases amyloidogenic pathway and rescues cognition and mitochondrial energy metabolism in middle-aged female 3xTg-AD mouse model of Alzheimer's disease
    Jonathas Rodrigo dos Santos, Carlos Henrique Rocha Catalão, Anderson Vulczak, Ana Elisa Caleiro Seixas Azzolini, Luciane C. Alberici · 2024 · Journal of Alzheimer s Disease
31. Effect of Reserpine on the Behavioral Defects, Aβ-42 Deposition and NGF Metabolism in Tg2576 Transgenic Mouse Model for Alzheimer's Disease
    Jun Go, Sung Yong Choi, Ji Eun Kim, Young Ju Lee, Moon Hwa Kwak, Eun Kyoung Koh, Sung Hwa Song, Ji Eun Sung, Dae Youn Hwang · 2013 · Journal of Life Science
32. Altered APP trafficking drives amyloidogenic processing in primary neurons from the AppNL-F knock-in mouse model of Alzheimer's disease
    Yang Yu, Robin Ziyue Zhou, Per Nilsson, Bengt G. Winblad, Lars O. Tjernberg, Sophia Schedin‐Weiss · 2025 · Neurobiology of Disease
33. Alzheimer’s Disease, β-Amyloid Peptides, and Ubiquitin-Proteasome System: Nutritherapeutic Insights
    Philippe Yves Rémy Simon, Renaud David · 2025 · Neurodegenerative Diseases
34. Current Updates on the Regulation of Beta-Secretase Movement as a Potential Restorative Focus for Management of Alzheimer's Disease
    Syed Sayeed Ahmad, Mohammad Amjad Kamal · 2019 · Protein and Peptide Letters
35. Dale Schenk One Year Anniversary: Fighting to Preserve the Memories
    Cassia Overk, Eliezer Masliah · 2018 · Journal of Alzheimer s Disease
36. γ-Secretase Inhibitors – from Molecular Probes to New Therapeutics?
    Timothy Harrison, Dirk Beher · 2003 · Progress in medicinal chemistry
37. Molekulare Mechanismen der Alzheimer Erkrankung
    Christian Haass · 1999 · Springer eBooks
38. Pathogenic Aβ production by heterozygous PSEN1 mutations is intrinsic to the mutant protein and not mediated by conformational hindrance of wild-type PSEN1
    Vanessa Kurth, Isabella Ogorek, Carolina Münch, Javier López-Rı́os, Solenne Ousson, Sandra Lehmann, Katja Nieweg, Anton Roebroek, Claus U. Pietrzik, Dirk Beher et al. · 2023 · Journal of Biological Chemistry
39. An Insight into Medicinal Chemistry and SAR Studies of Cholinesterase and BACE-1 Inhibitors for Alzheimer's Disease
    Abhimannu Shome, Keshav Taruneshwar Jha, Chahat, Viney Chawla, Pooja A. Chawla · 2024 · CNS & Neurological Disorders - Drug Targets
40. Centella asiatica improves cognitive function and alters the hippocampal metabolome of aged Tg2576 and wild-type mice
    Donald G. Matthews, Mona Khorani, Gerd Bobe, Maya A. Caruso, Armando Alcázar Magaña, Nora E. Gray, Joseph F. Quinn, Jan Frederik Stevens, Claudia S. Maier, Amala Soumyanath · 2024 · Journal of Alzheimer s Disease Reports
41. Lancao decoction alleviates Alzheimer’s disease: Depending on activating CaMKII to protect neuronal refunction by reducing β-amyloid in the hippocampus
    Lei Wu, Yan Sun, Lingang Zhao, Shan Xing, Ruiyi Liu, Nga Lee Wong, Yuesong Lin, Chenghao Song, Chao Lu, Hailou Zhang · 2025 · Journal of Ethnopharmacology
42. Amyloidosis and Other Protein Deposition Diseases
    Merrill Douglas Benson · 2013 · Elsevier eBooks
43. Endocannabinoids and Alzheimer’s disease
    Steven G. Fagan, Veronica A. Campbell · 2015 · Elsevier eBooks
44. Downregulation of SNX27 expression does not exacerbate amyloidogenesis in the APP/PS1 Alzheimer's disease mouse model
    Michael Milne, Lei Qian, Marion T. Turnbull, Genevieve Kinna, Brett M. Collins, Rohan David Teasdale, Elizabeth Jane Coulson · 2019 · Neurobiology of Aging
45. Reduced brain volumes in mice expressing APP-Austrian mutation but not in mice expressing APP-Swedish–Austrian mutations
    Bianca Van Broeck, Greet Vanhoutte, Ivy Cuijt, Sandra Pereson, Geert Joris, Jean‐Pierre Timmermans, Annemie Van der Linden, Christine Van Broeckhoven, Samir Kumar‐Singh · 2008 · Neuroscience Letters
46. Human brain β-secretase contains heparan sulfate glycoconjugates
    Akira Matsumoto, Reiko Matsumoto, Taira Enomoto, Hisamitsu Baba · 1996 · Neuroscience Letters
47. Rodent Models of Alzheimer’s Disease
    Abhinav Singh, Shampa Ghosh, Dr. Krishna Kumar Singh, Bhuvaneshwar Yarlagadda, Jitendra Kumar Sinha · 2026 · Contemporary clinical neuroscience
48. Protective Effects of Cirsium japonicum var. maackii Flower on Amyloid Beta25–35-Treated C6 Glial Cells
    Qi Pang, Sanghyun Lee, Eun Ju Cho, Ji-Hyun Kim · 2023 · Life
49. Identification of truncated C‐terminal fragments of the Alzheimer’s disease amyloid protein precursor derived from sequential proteolytic pathways
    Sébastien Mosser, Hermeto Gerber, Patrick C. Fraering · 2020 · Journal of Neurochemistry
50. The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities
    Renato Brandimarti, Elena Irollo, Olimpia Meucci · 2022 · Molecular Neurobiology
51. Double Mutations in a Patient with Early-Onset Alzheimer’s Disease in Korea: An APP Val551Met and a PSEN2 His169Asn
    Heewon Bae, Kyu Hwan Shim, Jang Yoo, YoungSoon Yang, Seong Soo A. An, Min Ju Kang · 2023 · International Journal of Molecular Sciences
52. What is the Link Between Protein Aggregation and Interneuronal Lesion Propagation in Neurodegenerative Disease?
    F. Garth · 2011 · InTech eBooks
53. A human brain proteolytic activity capable of cleaving natural β-amyloid precursor protein is affected by its substrate glycoconjugates
    Akira Matsumoto, Reiko Matsumoto, Taira Enomoto, Kyoko Itoh · 1998 · Neuroscience Letters
54. α7-Nicotinic Acetylcholine Receptors and β-Amyloid Peptides in Alzheimer’s Disease
    Dietrich Ernst Lorke, Georg A. Petroianu, Murat Öz · 2016 · Neuromethods
55. Amyloid-β and Mitochondrial Membranes: A Missing Link in Alzheimer’s Pathogenesis
    Aneta Houfkova, Monika Schmidt · 2026 · Molecular Neurobiology
56. Potentially Pathogenic SORL1 Mutations Observed in Autosomal-Dominant Cases of Alzheimer’s Disease Do Not Modulate APP Physiopathological Processing
    Charlotte Bauer, E. Duplan, Peter Saint-George-Hyslop, F. Checler · 2023 · Cells
57. Cerebrospinal fluid soluble insulin receptor levels in Alzheimer's disease
    Peter Thomas, Manon Leclerc, Kira M. Evitts, Caitlin Brown, Wyatt Miller, Angela J. Hanson, William A. Banks, Laura E. Gibbons, Kimiko Domoto‐Reilly, Suman Jayadev et al. · 2024 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
58. Protein aggregation in health and disease: A looking glass of two faces
    Guilherme Caldas de Andrade, Michelle F. Mota, Dinarte N Moreira-Ferreira, Jerson Lima Silva, Guilherme A. P. de Oliveira, Mayra A. Marques · 2024 · Advances in protein chemistry and structural biology
59. Disrupted cellular calcium homeostasis is responsible for Aβ‐induced learning and memory damage and lifespan shortening in a model of Aβ transgenic fly
    Kuan‐Chung Cheng, Chih‐Yuan Huang, Tsung‐Chi Hsieh, Hsueh‐Cheng Chiang · 2022 · IUBMB Life
60. Introduction to Alzheimer’s Disease
    Thamilarasan Manivasagam, Ravi Surya, Mariakuttikan Jayalakshmi, Arokiasamy Justin Thenmozhi, Asokan Prema, M. Walid Qoronfleh, Hanan Fahad Alharbi, Yoga Rajamani · 2023 · Nutritional neurosciences
61. Dementia: The Significance of Cerebral Metabolic Disturbances in Alzheimer's Disease. Relation to Parkinson's Disease
    Siegfried Hoyer, Lutz Frölich · 2007 · Springer eBooks
62. Alzheimer’s Disease—Molecular Defect, Public Perceptions and Stigma in South Africa
    Tando Maduna, Ben Loos · 2021 · Springer eBooks
63. Amyloid fil rouge from invertebrate up to human ageing: A focus on Alzheimer disease
    Magda de Eguileor, Annalisa Grimaldi, Laura Pulze, Francesco Acquati, Cristina Morsiani, Miriam Capri · 2022 · Mechanisms of Ageing and Development
64. Proteolytic Processing of the Amyloid Precursor Protein of Alzheimer’s Disease
    Stefan F. Lichtenthaler, Colin Louis Masters, Konrad T. Beyreuther · 2000 · Handbook of experimental pharmacology
65. Systematic interaction mapping reveals novel modifiers of neurodegenerative disease processes
    Jenny Russ · 2012 · edoc Publication server (Humboldt University of Berlin)
66. BACE Inhibitors
    Daniel F. Wyss, Jared N. Cumming, Corey O. Strickland, Andrew W. Stamford · 2016 · Methods and principles in medicinal chemistry
67. CAA in Transgenic Mouse Models of Alzheimer’s Disease
    Greg M. Cole, Fusheng Yang · 2000 · Springer eBooks
68. Alzheimer's Disease BACE Proteases
    Steffen Roßner, Stefan F. Lichtenthaler · 2008 · Springer eBooks
69. Screening of Beta-Secretase Inhibitors by Capillary Electrophoresis-Mass Spectrometry
    Jan Schejbal, Roman Řemínek, Zdeněk Glatz · 2019 · Methods in molecular biology
70. Models of Alzheimer’s Disease
    Mengqi Chen, Doris Kretzschmar, Giuseppe Verdile, Michael T. Lardelli · 2013 · Elsevier eBooks
71. Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)
    И. А. Мазеркина · 2025 · Safety and Risk of Pharmacotherapy
72. Amyloid Precursor Protein (APP) A673T Mutation as a Model for Developing Preventive Strategies in Alzheimer’s Disease
    Isabel Liste · 2025
73. Impact of Golgi dynamics and Golgi morphology on the regulation of glycosylation
    Paul A. Gleeson · 2026 · Biochimica et Biophysica Acta (BBA) - General Subjects
74. The Dynamic Role of the Golgi Apparatus in Neuronal Function and Alzheimer’s Disease
    Lou Fourrière, Paul A. Gleeson · 2026 · Sub-cellular biochemistry/Subcellular biochemistry
75. Phosphate‐ and pH ‐dependent self‐assembly of recombinant spider silk proteins
    Vanessa Tanja Trossmann, Veronika Hovanová, Tim Schiller, Martin Humeník, Erik Sedlák, Thomas Scheibel · 2026 · Protein Science
76. Peptide-based therapeutics in the management of Alzheimer’s disease (AD) and their potential to develop novel strategies
    S. U. Nabi, Iyman Rasool, Andleeb Khan, Abrar Ul Haq, Iqra Hussain, Mosin Saleem Khan, Sabhiya Majid, Summya Rashid, Shahzada Mudasir Rashid, Nouroz Sehar et al. · 2026 · Metabolic Brain Disease
77. Turning defense into damage: HIV-driven amyloidogenesis and neurotoxicity
    Feng Gu, Badeia Saed, Mojgan H. Naghavi · 2026 · mBio
78. Pharmacology of nivegacetor (RG6289), a potent and selective gamma secretase modulator in clinical development for the treatment of Alzheimer’s disease
    Lothar Lindemann, Julie Lambotte, Judith Rothe, Jürg Messer, Catherine Diener, Solen Pichereau, Carina Cantrill, Thomas Mueggler, Michael Honer, Jennifer Beck et al. · 2026 · Frontiers in Pharmacology
79. Mechanistic Studies of the Effect of Presenilins 1 and 2 on APP Metabolism
    Dennis J. Selkoe, Weiming Xia, J. Zhang, Marcia Berman Podlisny, Cynthia Ann Lemere, Martin Citron, Edward H. Koo · 1998 · Springer eBooks
80. The Molecular Basis of Alzheimer's Disease
    Martin Ingelsson, Bradley T. Hyman · 2007 · Elsevier eBooks
81. Frontiers in Clinical Drug Research - Alzheimer Disorders
    Atta-ur-rahman, Chrystelle Mavoungou, K. S. Zimmerman, John Wright, J. Harding, R. Cavallaro, A. Fuso, Y. Yoshiyama, Zaciragic Asija, A. Clifford et al. · 2015 · BENTHAM SCIENCE PUBLISHERS eBooks
82. Mitofusin 1 and 2 overexpression reduces AβO-mediated ER stress and apoptosis in N2a APPswe cells
    Min Kyoung Kam, Su-Min Jung, Ga Eun Lee, Sung Woo Lee, Hong Jun Lee, Young‐Ho Park, Dong‐Seok Lee · 2024 · Cellular and Molecular Biology
83. Modulation of BACE1 Activity as a Potential Therapeutic Strategy for Treating Alzheimer’s Disease
    David William Klaver, Giuseppina Tesco · 2014 · Elsevier eBooks
84. Neurotoxicity of amyloid β proteins
    Naoki Hattori, Kaori Kitagawa, Yasuhisa Nakayama, Chiyoko Inagaki · 2008 · Folia Pharmacologica Japonica
85. Strategies for Inhibiting Protein Aggregation: Therapeutic Approaches to Protein-Aggregation Diseases
    Jennifer D. Lanning, Stephen C. Meredith · 2011 · Springer eBooks
86. Epigenome-Wide DNA Methylation and Histone Modification of Alzheimer's Disease
    Ankush Bansal, Tiratha Raj Singh · 2019 · Elsevier eBooks
87. Amyloidosis and Other Protein Deposition Diseases
    Merrill Douglas Benson · 2022 · Elsevier eBooks
88. Protein–Protein Interactions in Neurodegenerative Diseases
    Krishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi, Nupur Nagar · 2023 · Springer eBooks
89. Mechanism for β-amyloid Overproduction in Alzheimer Disease
    Vladimir Volloch · 1997 · Humana Press eBooks
90. Future Strategies for Development of Novel BACE Inhibitors: Anti‐APP β‐Site Antibody and APP Binding Small Molecule Approaches for Alzheimer's Disease
    Beka Solomon, Michal Arbel‐Ornath, Clare A. Peters-Libeu, Varghese John · 2010 · Wiley eBooks
91. Proteolysis in Neurodegenerative Diseases
    VIVIAN Y. H. HOOK, Liane Mende‐Mueller · 2001 · Humana Press eBooks
92. Heparan Sulfate in the Amyloidosis and Inflammation of Alzheimer’s Disease
    P.W. O′Callaghan · 2011 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
93. Mechanistic and Metaphorical Connections Between NF-KB and the Secreted Alzheimer’s β-Amyloid Precursor Protein
    Steven W. Barger, Xianrong R. Mao, Andrea M. Moerman-Herzog, A. Ranganathan · 2000 · Research and perspectives in neurosciences
94. Yeast as a Model for Studying Aβ Aggregation, Toxicity and Clearance
    Prashant Bharadwaj · 2011 · Australasian Journal of Paramedicine
95. Drosophila Melanogaster as a Model Organism for Dementia
    Maria E. Giannakou, Damian C. Crowther · 2010 · Neuromethods
96. Antibody-based therapeutics
    Tatsuhiko Tachibana, Takashi Kuwabara · 2019 · Drug Metabolism and Pharmacokinetics
97. SERF deletion modifies amyloid aggregation in a mouse model of Alzheimer’s disease
    Esther Stroo, Leen Janssen, Olga Sin, Wytse Hogewerf, Mirjam H. Koster, Liesbeth Harkema, Sameh A. Youssef, Natalie Beschörner, Anouk H. G. Wolters, Björn Bakker et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
98. Metabolic Abnormalities in Alzheimer Disease
    Florian M. Gebhardt, Peter Ronald Dodd · 2008 · Springer eBooks
99. TNF⍺-driven Aβ aggregation, synaptic dysfunction and hypermetabolism in human iPSC-derived cortical neurons
    Alicia González Díaz, Elisa Belli, Benedetta Mannini, Gustavo Antonio Urrutia, Michele Vendruscolo · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
100. Analysis of Reelin function in the molecular mechanisms underlying Alzheimer’s disease
     Daniela Paola Rossi · 2013 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)